SCHEMBL28147339

SCHEMBL28147339

O=[SH](=O)Cc1ccc(-c2cc(Cl)cnc2O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.37
PTGS2 P35354 13/20 0.34
PTGS1 P23219 7/20 0.34
MAP4K4 O95819 2/20 0.34
ABCC4 O15439 1/20 0.33
ABCB11 O95342 1/20 0.33
PDE4D Q08499 1/20 0.33
MAPK14 Q16539 1/20 0.33
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28146261 0.82 FFAR4 (0.34) FFAR4PTGS2PTGS1MAP4K4ABCC4
SCHEMBL27585000 0.76 PTGS2 (0.62) FFAR4PTGS2PTGS1ABCC4ABCB11
SCHEMBL6069906 0.72 PTGS2 (0.63) PTGS2PTGS1MAP4K4ABCC4ABCB11
SCHEMBL5904269 0.71 NPSR1 (0.49) PTGS2MAP4K4
SCHEMBL5773780 0.71 ALDH1A1 (0.37) PTGS2PTGS1ABCC4ABCB11PDE4D
SCHEMBL27635253 0.68 FFAR4 (0.49) FFAR4PTGS2PTGS1
SCHEMBL27885119 0.68 USP7 (0.70) MAP4K4FYN
SCHEMBL14198821 0.67 IDO1 (0.46)
SCHEMBL5989061 0.67 CYP2A6 (0.50) PTGS2PTGS1
SCHEMBL28051403 0.67 USP7 (0.57) MAP4K4FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106632002-A Preparation technology of etoricoxib and reference substance 5-chloro-3-(4-(methyl sulphonyl)phenyl)-2,3-bipyridine of etoricoxib 贵州大学 2017-05-10 CN disclosed